{
    "2021-03-09": [
        [
            {
                "time": "",
                "original_text": "医药行业周报：逐步布局一季报高增长核心资产",
                "features": {
                    "keywords": [
                        "医药",
                        "行业",
                        "一季报",
                        "高增长",
                        "核心资产"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "【异动股】康龙化成(03759-HK)涨3.95%",
                "features": {
                    "keywords": [
                        "康龙化成",
                        "异动股",
                        "涨3.95%"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "国盛证券 - 医药生物行业周报：全民免疫迫在眉睫，新冠疫苗的热点问题怎么看【行业研究】",
                "features": {
                    "keywords": [
                        "医药生物",
                        "全民免疫",
                        "新冠疫苗",
                        "热点问题"
                    ],
                    "sentiment_score": 0.65,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "医药生物行业半月谈：医药行业估值性价比开始凸显，适时布局高景气赛道和高成长个股",
                "features": {
                    "keywords": [
                        "医药生物",
                        "估值性价比",
                        "高景气赛道",
                        "高成长个股"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "69只港股获南向资金大比例持有",
                "features": {
                    "keywords": [
                        "港股",
                        "南向资金",
                        "大比例持有"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}